drugset / Trial / NCT03487848
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate daclatasvir in combination with sofosbuvir given to children with chronic hepatitis C infection
Timeline
- Start
- 2018-06-25
- Primary completion
- 2018-10-18
- Completion
- 2020-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daclatasvir | Small molecule | — | — |
| Subject | Sofosbuvir | Small molecule | — | — |